Monday, April 2, 2018

Endo International Places Second Temporary Hold on Compounding ...

www.pharmalive.com/endo-international-places-a-second-temporary-hold-on-compo...
7 hours ago - The FDA's guidance, Endo said, states that because “compounded drug products are subject to a lower regulatory standard than FDA-approved drugs, they should only be used by patients whose medical needs cannot be met by an FDA-approved drug.”
Post a Comment